Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $871,780 - $1.07 Million
25,269 New
25,269 $1.06 Million
Q4 2020

Feb 12, 2021

SELL
$53.08 - $69.86 $291,568 - $383,740
-5,493 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$51.29 - $65.09 $281,735 - $357,539
5,493 New
5,493 $292,000
Q1 2019

May 14, 2019

SELL
$36.91 - $55.7 $269,443 - $406,610
-7,300 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$36.49 - $51.72 $21,894 - $31,032
600 Added 8.96%
7,300 $287,000
Q3 2018

Nov 14, 2018

SELL
$46.5 - $53.55 $460,350 - $530,145
-9,900 Reduced 59.64%
6,700 $345,000
Q2 2018

Aug 14, 2018

SELL
$35.0 - $48.9 $198,870 - $277,849
-5,682 Reduced 25.5%
16,600 $779,000
Q1 2018

May 15, 2018

BUY
$31.7 - $44.1 $706,339 - $982,636
22,282 New
22,282 $791,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.